Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Axis NIFTY Healthcare ETF Reg (G) |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-0.16 |
Equity |
99.91 |
Trep |
0.25 |
|
|
Concentration Analysis |
Top 5 Holdings |
54.44% |
Top 10 Holdings |
78.47% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
78.08 |
Healthcare |
21.83 |
Cash |
0.09 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.36 |
PE Ratio |
36.54 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
20.66 |
Max Healthcare Institute Limited |
9.01 |
Cipla Limited |
8.96 |
DIVI LABORATORIES LTD |
8.10 |
Dr Reddys Laboratories Limited |
7.71 |
Apollo Hospitals Enterprise Limited |
7.39 |
Lupin Limited |
5.41 |
Fortis Health Care Ltd |
3.91 |
Torrent Pharmaceuticals Limited |
3.73 |
Aurobindo Pharma Limited |
3.59 |
Alkem Laboratories Limited |
2.87 |
MANKIND PHARMA LIMITED |
2.83 |
Laurus Labs Limited |
2.65 |
Glenmark Pharmaceuticals Limited |
2.56 |
Zydus Lifesciences Limited |
2.45 |
IPCA Laboratories Limited |
2.31 |
Abbott India Limited |
1.77 |
Biocon Limited |
1.70 |
Syngene International Limited |
1.52 |
Granules India Limited |
0.78 |
Clearing Corporation of India Ltd |
0.25 |
Net Receivables / (Payables) |
-0.16 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|